Screening compound: InChI=1S/C18H15N7O/c26-18(14-11-20-25-8-4-7-19-17(14)25)23-9-10-24-15(12-23)21-22-16(24)13-5-2-1-3-6-13/h1-8,11H,9-10,12H2

Screening compound: InChI=1S/C18H15N7O/c26-18(14-11-20-25-8-4-7-19-17(14)25)23-9-10-24-15(12-23)21-22-16(24)13-5-2-1-3-6-13/h1-8,11H,9-10,12H2
Screening compound: InChI=1S/C18H15N7O/c26-18(14-11-20-25-8-4-7-19-17(14)25)23-9-10-24-15(12-23)21-22-16(24)13-5-2-1-3-6-13/h1-8,11H,9-10,12H2 alternative view

Chemical Structure Depiction of ChemDiv screening compound
InChI=1S/C18H15N7O/c26-18(14-11-20-25-8-4-7-19-17(14)25)23-9-10-24-15(12-23)21-22-16(24)13-5-2-1-3-6-13/h1-8,11H,9-10,12H2

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T815-0352

Molecular Formula

C18H15N7O (C18 H15 N7 O)

Compound Name

3-phenyl-7-{pyrazolo[1,5-a]pyrimidine-3-carbonyl}-5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyrazine

IUPAC name

3-phenyl-7-{pyrazolo[15-a]pyrimidine-3-carbonyl}-5H6H7H8H-[124]triazolo[43-a]pyrazine

SMILES

O=C(c1c2ncccn2nc1)N1Cc2nnc(-c3ccccc3)n2CC1

MDL Number (MFCD)

InChI=1S/C18H15N7O/c26-18(14-11-20-25-8-4-7-19-17(14)25)23-9-10-24-15(12-23)21-22-16(24)13-5-2-1-3-6-13/h1-8,11H,9-10,12H2 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Anti-Inflammatory Library (24602 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Protein-Protein Interaction Library (218420 compounds)

SmartTM Library (51161 compounds)

TLR-8 ligands Library (674 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Indoleamine 2,3-dioxygenase 1 Focused Library (5816 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Immune system
  • Female
  • Skin
  • Immune system
  • Cancer
  • Digestive system
  • Female
  • Hemic and lymphatic
  • Metabolic
  • Immune system
Mechanism of action:
  • PPI modulators
  • Receptor's ligands
Targets:
  • Others
  • Others
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with InChI=1S/C18H15N7O/c26-18(14-11-20-25-8-4-7-19-17(14)25)23-9-10-24-15(12-23)21-22-16(24)13-5-2-1-3-6-13/h1-8,11H,9-10,12H2 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound InChI=1S/C18H15N7O/c26-18(14-11-20-25-8-4-7-19-17(14)25)23-9-10-24-15(12-23)21-22-16(24)13-5-2-1-3-6-13/h1-8,11H,9-10,12H2?
Check Price and Availability of InChI=1S/C18H15N7O/c26-18(14-11-20-25-8-4-7-19-17(14)25)23-9-10-24-15(12-23)21-22-16(24)13-5-2-1-3-6-13/h1-8,11H,9-10,12H2, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of InChI=1S/C18H15N7O/c26-18(14-11-20-25-8-4-7-19-17(14)25)23-9-10-24-15(12-23)21-22-16(24)13-5-2-1-3-6-13/h1-8,11H,9-10,12H2 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for InChI=1S/C18H15N7O/c26-18(14-11-20-25-8-4-7-19-17(14)25)23-9-10-24-15(12-23)21-22-16(24)13-5-2-1-3-6-13/h1-8,11H,9-10,12H2
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for InChI=1S/C18H15N7O/c26-18(14-11-20-25-8-4-7-19-17(14)25)23-9-10-24-15(12-23)21-22-16(24)13-5-2-1-3-6-13/h1-8,11H,9-10,12H2
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of InChI=1S/C18H15N7O/c26-18(14-11-20-25-8-4-7-19-17(14)25)23-9-10-24-15(12-23)21-22-16(24)13-5-2-1-3-6-13/h1-8,11H,9-10,12H2 available by request